UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

Clinical cancer research, 2018-12, Vol.24 (23), p.5850-5859

2018

Volltextzugriff (PDF)

Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma

Nature communications, 2016-04, Vol.7 (1), p.11185-11185, Article 11185

2016

Volltextzugriff (PDF)

Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances

Neoplasia (New York, N.Y.), 2023-05, Vol.39, p.100895-100895, Article 100895

2023

Volltextzugriff (PDF)

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data

Frontiers in oncology, 2022-07, Vol.12, p.958637-958637

2022

Volltextzugriff (PDF)

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization

Journal of translational medicine, 2019-09, Vol.17 (1), p.321-321, Article 321

2019

Volltextzugriff (PDF)

The Role of NG2 Proteoglycan in Glioma

Translational oncology, 2016-02, Vol.9 (1), p.57-63

2016

Volltextzugriff (PDF)

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

Molecular therapy. Methods & clinical development, 2022-12, Vol.27, p.415-430

2022

Volltextzugriff (PDF)

The current landscape of immunotherapy for pediatric brain tumors

Nature cancer, 2022-01, Vol.3 (1), p.11-24

2022

Volltextzugriff (PDF)

Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data

Current oncology reports, 2023-08, Vol.25 (8), p.847-855

2023

Volltextzugriff (PDF)

Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors

Paediatric drugs, 2020-02, Vol.22 (1), p.45-54

2020

Volltextzugriff (PDF)

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab

JAMA ophthalmology, 2014-01, Vol.132 (1), p.111

2014

Volltextzugriff (PDF)

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial

Journal of clinical oncology, 2018-12, Vol.36 (34), p.JCO2017764720-3395

2018

Volltextzugriff (PDF)

Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (6), p.1029-1031

2022

Volltextzugriff (PDF)

A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study

Clinical cancer research, 2021-05, Vol.27 (9), p.2442-2451

2021

Volltextzugriff (PDF)

RNA aggregates harness the danger response for potent cancer immunotherapy

Cell, 2024-05, Vol.187 (10), p.2521-2535.e21

2024

Volltextzugriff (PDF)

Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy

Pediatric blood & cancer, 2020-12, Vol.67 (12), p.e28478-n/a

2020

Volltextzugriff (PDF)

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

Pediatric blood & cancer, 2013-05, Vol.60 (5), p.776-782

2013

Volltextzugriff (PDF)

Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity

Pediatric neurology, 2020-06, Vol.107, p.7-15

2020

Volltextzugriff (PDF)

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

Oncotarget, 2023-05, Vol.14 (1), p.449-449

2023

Volltextzugriff (PDF)

ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma

Neuro-oncology (Charlottesville, Va.), 2020-03, Vol.22 (3), p.345-356

2020

Volltextzugriff (PDF)

Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial

Pediatric blood & cancer, 2021-02, Vol.68 (2), p.e28756-n/a

2021

Volltextzugriff (PDF)

Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups

Clinical cancer research, 2015-01, Vol.21 (1), p.184-192

2015

Volltextzugriff (PDF)

Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors

Expert review of clinical immunology, 2024-08, p.1-10

2024

Volltextzugriff (PDF)

An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)

Journal of neuro-oncology, 2015-05, Vol.123 (1), p.85-91

2015

Volltextzugriff (PDF)

1 – 25 von 576

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(508)
Mit Volltextzugriff
(484)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(331)
Life Sciences & Biomedicine
(241)
Humans
(176)
Female
(94)
Male
(78)
Physical Sciences
(59)
Technology
(58)
Adult
(56)
Oncology
(51)
Middle Aged
(49)
Animals
(40)
Child
(40)
Neurosciences & Neurology
(38)
Science & Technology - Other Topics
(38)
Aged
(37)
Retrospective Studies
(37)
Clinical Neurology
(34)
Chemistry
(30)
Pediatrics
(29)
Physics
(28)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(12)

Menü

Weitere Dienste

Einstellungen

Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy

Spatial and temporal homogeneity of driver mutations in diffuse intrinsic pontine glioma

Why haven't we solved intracranial pediatric ependymoma? Current questions and barriers to treatment advances

Safety of Tumor Treating Fields (TTFields) therapy in pediatric patients with malignant brain tumors: Post-marketing surveillance data

Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralization

The Role of NG2 Proteoglycan in Glioma

Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β

The current landscape of immunotherapy for pediatric brain tumors

Cellular Therapy for Children with Central Nervous System Tumors: Mining and Mapping the Correlative Data

Molecularly Targeted Agents in the Therapy of Pediatric Brain Tumors

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab

Extensive Molecular and Clinical Heterogeneity in Patients With Histologically Diagnosed CNS-PNET Treated as a Single Entity: A Report From the Children's Oncology Group Randomized ACNS0332 Trial

Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1 fusion and responding to entrectinib

A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium Study

RNA aggregates harness the danger response for potent cancer immunotherapy

Pediatric diffuse leptomeningeal glioneuronal tumor: Two clinical cases of successful targeted therapy

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study

Immunotherapy Approaches for Pediatric CNS Tumors and Associated Neurotoxicity

Addendum: Histological and molecular analysis of a progressive diffuse intrinsic pontine glioma and synchronous metastatic lesions: a case report

ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma

Phase 1 study of pomalidomide in children with recurrent, refractory, and progressive central nervous system tumors: A Pediatric Brain Tumor Consortium trial

Molecular characterization of choroid plexus tumors reveals novel clinically relevant subgroups

Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors

An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)

Suchergebnisse filtern